These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28215359)

  • 21. Nephrolithiasis as a risk factor of chronic kidney disease: a meta-analysis of cohort studies with 4,770,691 participants.
    Zhe M; Hang Z
    Urolithiasis; 2017 Oct; 45(5):441-448. PubMed ID: 27837248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity and Kidney Disease: Hidden Consequences of the Epidemic.
    Kovesdy CP; Furth SL; Zoccali C;
    Am J Hypertens; 2017 Mar; 30(3):328-336. PubMed ID: 28203687
    [No Abstract]   [Full Text] [Related]  

  • 23. Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies.
    Roughley MJ; Belcher J; Mallen CD; Roddy E
    Arthritis Res Ther; 2015 Apr; 17(1):90. PubMed ID: 25889144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Obesity and kidney disease - renal consequences of an "epidemic"].
    Schiffl H; Lang SM
    Dtsch Med Wochenschr; 2017 Sep; 142(19):1466-1472. PubMed ID: 28938511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity and renovascular disease.
    Zhang X; Lerman LO
    Am J Physiol Renal Physiol; 2015 Aug; 309(4):F273-9. PubMed ID: 26041447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. World Kidney Day 2009: problems and challenges in the emerging epidemic of kidney disease.
    Szczech LA; Harmon W; Hostetter TH; Klotman PE; Powe NR; Sedor JR; Smedberg P; Himmelfarb J
    J Am Soc Nephrol; 2009 Mar; 20(3):453-5. PubMed ID: 19244576
    [No Abstract]   [Full Text] [Related]  

  • 27. Epidemiology of obesity and chronic kidney disease.
    Ross WR; McGill JB
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):325-35. PubMed ID: 17045219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity and kidney disease: hidden consequences of the epidemic.
    Kovesdy CP; Furth SL; Zoccali C;
    Intern Med J; 2017 Feb; 47(2):134-143. PubMed ID: 28201856
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic kidney disease: a hidden epidemic.
    Polenakovic M; Sikole A
    Prilozi; 2008 Jul; 29(1):5-9. PubMed ID: 18708996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity-related kidney disease.
    Snyder S; Turner GA; Turner A
    Prim Care; 2014 Dec; 41(4):875-93. PubMed ID: 25439539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of nephrolithiasis with hypertension and obesity: a review.
    Obligado SH; Goldfarb DS
    Am J Hypertens; 2008 Mar; 21(3):257-64. PubMed ID: 18219300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence.
    Lastra G; Manrique C; Sowers JR
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):365-73. PubMed ID: 17045222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between obesity and risk of chronic kidney disease: A nationwide Cohort study in Taiwan.
    Lai YJ; Hu HY; Lee YL; Ku PW; Yen YF; Chu D
    Nutr Metab Cardiovasc Dis; 2017 Nov; 27(11):1008-1014. PubMed ID: 28986076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The need to revisit ochratoxin A risk in light of diabetes, obesity, and chronic kidney disease prevalence.
    Chen C; Wu F
    Food Chem Toxicol; 2017 May; 103():79-85. PubMed ID: 28263864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrolithiasis as a systemic disorder.
    Sakhaee K
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):304-9. PubMed ID: 18408483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of obesity in chronic kidney disease: what is the best measure?
    Zoccali C; Torino C; Tripepi G; Mallamaci F
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):641-6. PubMed ID: 23010758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Participation in a Structured Weight Loss Program and All-Cause Mortality and Cardiovascular Morbidity in Obese Patients With Chronic Kidney Disease.
    MacLaughlin HL; Hall WL; Condry J; Sanders TA; Macdougall IC
    J Ren Nutr; 2015 Nov; 25(6):472-9. PubMed ID: 26143293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic kidney disease in the Arab world: a call for action.
    Farag YM; Kari JA; Singh AK
    Nephron Clin Pract; 2012; 121(3-4):c120-3. PubMed ID: 23208083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing care for Canadians with diabetic nephropathy in 2015.
    Lloyd A; Komenda P
    Can J Diabetes; 2015 Jun; 39(3):221-8. PubMed ID: 25805325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.